Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02046005 · ClinicalTrials.gov registry record · NA
Personalized Risk Estimator for Rheumatoid Arthritis Family Study
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 238
- Enrollment target
NCT02046005 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 238 participants.
The verdict
NCT02046005, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
Study Summary
The purpose of this study is to understand how personalized risk factors for rheumatoid arthritis (RA) may impact willingness to change behaviors associated with RA. The investigators have developed a personalized risk estimator for RA based on demographics, family history, biomarkers and behaviors related to RA risk. Eligible participants have a first degree relative with RA but do not have RA themselves. Participants who meet eligibility and consent to the study will be randomized to receive either standard information about RA, the online personalized RA risk tool, or the online personalized RA risk tool with guidance from a health educator. Participants will be followed to measure willingness to change RA risk behaviors. The investigators hypothesize that participants who receive the online personalized RA risk tool and health education will be more willing to change RA risk behaviors compared to participants that receive standard RA information.
Interventions
- BEHAVIORAL PRE-RA
- BEHAVIORAL PRE-RA Plus
- BEHAVIORAL General Rheumatoid Arthritis Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2014-01 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02046005
The ClinicalTrials.gov registry entry for NCT02046005 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PRE-RA is the first listed.
NCT02046005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02046005 about?
NCT02046005 is a clinical study titled "Personalized Risk Estimator for Rheumatoid Arthritis Family Study". The purpose of this study is to understand how personalized risk factors for rheumatoid arthritis (RA) may impact willingness to change behaviors associated with RA. The investigators have developed a personalized risk estimator for RA based on demographics, family history, biomarkers and behaviors ...
What is the current status of trial NCT02046005?
This trial is currently completed. It is a NA study. The enrollment target is 238 participants. The study started on 2014-01. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02046005?
The interventions under investigation include: PRE-RA (BEHAVIORAL), PRE-RA Plus (BEHAVIORAL), General Rheumatoid Arthritis Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT02046005?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.